Horizon Technology Finance Management

Onkos Surgical Inc. is a privately-held company based in Parsippany, New Jersey, focused on providing advanced technologies and solutions for surgical oncologists. Founded in 2014, Onkos Surgical is dedicated to transforming the treatment of musculoskeletal cancers and complex orthopedic conditions. The company offers innovative products such as GenVie, a magnesium bone scaffolding technology, and the ELEOS Proximal Tibia, a 3D printed limb salvage replacement. By leveraging cutting-edge techniques in virtual surgical planning, 3D modeling and printing, and personalized surgical planning, Onkos Surgical aims to enhance patient outcomes and improve the overall experience for both patients and healthcare professionals.

Finexio is a B2B payment network that offers a streamlined solution for accounts payable payments, primarily targeting medium and large corporations. The company’s platform simplifies the payment process by identifying suppliers eligible for electronic payments and routing these transactions without the need for bank account information. This approach eliminates the reliance on paper checks, significantly reducing associated costs such as transaction fees and currency conversion charges. By integrating with major payment aggregators, accounts payable automation tools, and procurement software, Finexio enhances payment efficiency, allowing businesses to transfer funds directly to suppliers’ bank accounts at lower rates than traditional payment methods.

Ursa Space Systems Inc. is a geospatial services company that specializes in providing aerial and space-based data products to enhance geographic mapping and location-based information services. Founded in 2014 and headquartered in Ithaca, New York, the company delivers imagery and information products that support market and weather forecasting, agricultural yield optimization, disaster response, and military intelligence. Ursa's offerings include the Ursa Global Oil Storage Monitoring solution, which tracks global oil storage for clients such as hedge funds, commodities traders, banks, and oil companies. The company serves various sectors, including precision agriculture, business intelligence, humanitarian relief, and civil protection, as well as mapping and traffic applications. By utilizing data from radar satellites, Ursa Space Systems aims to bring transparency to global markets, enabling traders and analysts in the finance and energy industries to make more informed decisions.

GT Medical Technologies, Inc. is a medical device company based in Tempe, Arizona, dedicated to improving the lives of patients with brain tumors. Founded in 2017, the company has developed an innovative treatment approach through its flagship product, GammaTile, which combines a biocompatible, conformable collagen matrix with brachytherapy radiation seeds. This technology is designed to address the limitations of existing treatments for recurrent brain tumors, providing a bioresorbable solution that enhances treatment efficacy. GammaTile is protected by multiple patents and has the potential to benefit a significant patient population, with an estimated 176,000 patients diagnosed annually in the United States. To date, clinical trials at Barrow Neurological Institute have demonstrated promising outcomes, with significant clinical improvements observed in patients treated with this novel device.

Vesta Healthcare is a technology and clinical services organization based in New York, specializing in connecting caregivers to care teams through its innovative health care platform. The company offers 24/7 telehealth support aimed at caregivers and care recipients, particularly focusing on high-need, frail senior populations. Vesta partners with home care agencies, health plans, and healthcare providers to develop value-based population health programs that prioritize clinical quality and improved health outcomes. Founded in 2008 and originally known as Hometeam Technologies, Inc., Vesta Healthcare has established itself as a leader in enhancing caregiver insights and facilitating personalized engagement in the healthcare setting.

Parse Biosciences is a biotechnology company specializing in single-cell analysis and sequencing solutions. Founded in 2018 and based in Seattle, Washington, the company focuses on developing innovative technologies that simplify the sequencing process for researchers. By employing combinatorial cDNA barcoding directly within cells, Parse Biosciences eliminates the necessity for complex and costly microfluidic instruments. This technology allows for the fixing, freezing, and storage of samples, enabling researchers to conduct experiments with samples collected on different dates in a single run. This capability enhances sample handling and minimizes errors, ultimately improving the accuracy of results. The company aims to increase gene detection in individual cells while addressing common challenges associated with single-cell sequencing, thereby advancing research in various scientific fields.

Mirantis, Inc. is a technology company that specializes in providing software, services, and training for open source cloud environments. It offers a range of solutions including OpenStack distribution software, cloud-ready application tools like Murano, and Containers-as-a-Service for developers and operators. The company empowers organizations to build and manage open cloud infrastructure, facilitating a public cloud experience across various infrastructures while eliminating vendor lock-in. Mirantis also provides infrastructure solutions that support virtualization, application deployment, and cloud management, enabling seamless development and operations. Its portfolio includes training programs for DevOps professionals and managed services for implementation and migration. Founded in 1993 and headquartered in Campbell, California, Mirantis has expanded its presence internationally, with offices in Russia, France, Poland, and Ukraine.

Elligo Health Research, Inc. is a healthcare organization focused on improving the clinical research landscape by bringing research directly to healthcare clinics. Founded in 2016 and headquartered in Austin, Texas, the company utilizes advanced healthcare informatics and electronic health records to enhance patient and physician participation in clinical trials. By enabling physicians to conduct trials within their practices, Elligo eliminates common barriers related to patient enrollment and study delays, while providing essential infrastructure and support. This approach not only accelerates the development of new pharmaceutical, biotechnology, and medical device products but also ensures that patients benefit from access to cutting-edge therapies without the logistical challenges of traditional trials. Elligo's model empowers physicians and offers patients the opportunity to contribute to clinical research, ultimately fostering advancements in healthcare for future generations.

Sonex Health, LLC, founded in 2014 and based in Rochester, Minnesota, specializes in developing micro-invasive surgical devices aimed at enhancing patient outcomes in orthopedic care. The company’s flagship product, the SX-One MicroKnife with Meerkat Technology, is designed for the ultrasound-guided treatment of carpal tunnel syndrome through a procedure known as Micro-invasive Carpal Tunnel Release. This innovative approach allows the surgery to be performed in a surgery center or office setting rather than a traditional operating room, resulting in quicker recovery times, improved cosmetic results, and reduced healthcare costs. The SX-One MicroKnife features an ultra-low-profile design that enables the procedure via a single micro-incision, which is significantly smaller than those used in conventional surgeries. This minimally invasive technique not only reduces surgical trauma but also facilitates a faster return to daily activities for patients, as immobilization is often unnecessary, allowing for immediate rehabilitation. Overall, Sonex Health is committed to advancing surgical methods that prioritize patient safety and cost-effectiveness.

Tallac Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative immunotherapies for cancer patients. Founded in 2018 and headquartered in Burlingame, California, the company specializes in creating conjugates of antibodies combined with potent toll-like receptor agonists. This approach aims to activate both innate and adaptive immunity, enabling targeted immune responses against various solid tumor malignancies. Through its advanced therapies, Tallac Therapeutics seeks to enhance the immune system's ability to combat cancer more effectively.

Viken Detection Corporation, founded in 2013 and headquartered in Newton, Massachusetts, specializes in the development and marketing of handheld X-ray instruments. The company offers a range of devices, including the Pb200i handheld XRF lead paint analyzer, which is utilized for various applications such as lead-based paint testing, environmental assessments, and materials compliance for hazardous substances. Viken Detection's technology also plays a critical role in security imaging and material identification, assisting law enforcement and safety inspection agencies in detecting concealed threats in vehicles and other locations, thereby enhancing public safety. In addition to its product offerings, the company provides leasing and financing services to accommodate businesses of all sizes. Viken Detection was formerly known as Heuresis Corporation, reflecting its evolution in the field of X-ray physics and analytical device design.

SafelyYou, Inc. is a technology company based in Berkeley, California, founded in 2015, that specializes in artificial intelligence software designed for managed Alzheimer's care. The company focuses on fall prevention by utilizing a camera system installed in patients' rooms to detect falls in real time and alert caregivers. Its AI-enabled technology analyzes patterns and signs that may indicate a potential fall, allowing for proactive intervention. SafelyYou's solutions aim to enhance the safety and well-being of individuals with Alzheimer's and other forms of dementia, facilitating improved medication adherence, behavioral monitoring, and overall care management in skilled nursing facilities and assisted living communities. By reducing the frequency and impact of falls, SafelyYou contributes to lowering hospitalization rates among this vulnerable population.

Unagi Scooters is an electric scooter manufacturer focused on providing innovative transportation solutions aimed at alleviating the challenges of urban commuting. The company designs high-performance electric scooters that are both eco-friendly and efficient, allowing users to navigate long distances on a single charge. Unagi's scooters are engineered to handle hilly terrains and deliver a smooth ride over uneven surfaces, offering a reliable alternative to conventional transportation methods. Through its products, Unagi seeks to enhance mobility while helping users save time and reduce costs associated with commuting, ultimately promoting a more sustainable mode of transport.

Evelo Biosciences, Inc., established in 2015, is a biotechnology company based in Cambridge, Massachusetts. It specializes in the discovery and development of a novel class of medicines known as monoclonal microbials, which are orally delivered and designed to modulate systemic immunology and biology by interacting with human cells in the gut. Evelo's pipeline includes EDP1815, currently in a Phase 1b clinical trial for psoriasis and atopic dermatitis, and EDP1503, in a Phase 1/2 study for various cancer types, including colorectal, triple-negative breast, and melanoma. The company aims to apply this innovative approach across a broad range of diseases, including autoimmune, immunoinflammatory, metabolic, neurological, neuroinflammatory conditions, and cancer.

Slingshot Aerospace, Inc. is a technology company that develops online tools and platforms to provide geospatial information for the aerospace and defense industries. With its suite of platforms, including Slingshot Earth, Slingshot Orbital, Slingshot Edge, and Slingshot Imagery, the company integrates data streams from various sources, such as satellites, drones, and ground-based sensors, to deliver critical insights that enhance decision-making for its clients. Operating from its headquarters in El Segundo, California, and an additional office in Austin, Texas, Slingshot Aerospace serves a diverse range of sectors, including energy, aerospace, insurance, military, government, engineering services, and emergency management. The company's mission is to empower both government and commercial space organizations by providing simulation and analytics solutions that improve mission success and ensure safe, reliable operations in complex environments.

Robin Healthcare, Inc. is a healthcare technology company founded in 2017 and headquartered in Berkeley, California, with an additional office in Austin, Texas. The company specializes in developing innovative solutions for the medical industry, including a smart assistant device, clinical documentation solutions, and services for order and medication entry, chart review, billing and coding, and referral management. Robin Healthcare provides comprehensive medical scribe services designed to alleviate administrative burdens on healthcare providers, thereby enhancing the doctor-patient experience. By integrating technology and trained medical scribes directly into electronic medical records, the company aims to streamline workflows and allow physicians to focus more on patient care.

Kodiak Robotics, Inc. is a technology company focused on developing autonomous systems specifically for long-haul trucking. Founded in 2018 and headquartered in Mountain View, California, the company specializes in autonomous vehicles, information technology, software, logistics, and robotics. Kodiak Robotics designs self-driving trucks that are capable of operating on highway routes, employing advanced sensor fusion systems and lightweight mapping techniques. By enabling vehicles to manage all aspects of highway driving, Kodiak aims to enhance operational efficiency and reduce costs for businesses in the logistics sector.

PDS Biotechnology Corporation is a clinical-stage biopharmaceutical company based in North Brunswick, New Jersey, focused on developing immunotherapies for cancer and infectious diseases. Founded in 2005, the company aims to prevent and treat various cancers, including cervical, ovarian, melanoma, leukemia, pancreatic, oral, multiple myeloma, anal, and vulvar cancers. PDS Biotechnology's product pipeline includes PDS0101, a treatment for HPV-related cancers; PDS0102, a pandemic influenza vaccine; and PDS0103, a series of immunotherapy products for non-viral cancers. The company's proprietary Versamune platform technology is designed to activate and direct the human immune system to effectively target and attack cancer cells, supporting its commitment to innovative cancer treatment solutions.

Nexii is a green construction technology company focused on creating sustainable and resilient buildings. By designing and manufacturing high-performance building solutions, Nexii aims to transform the construction industry to prioritize health, affordability, and sustainability. The company’s innovative approach significantly reduces construction timelines and costs, allowing clients to benefit from faster and more efficient building processes. Nexii's commitment to sustainability and resilience addresses the challenges posed by climate change, making its products a viable choice for modern construction needs.

Inbrace is a medical device company focused on revolutionizing orthodontic treatment with its innovative device that aligns teeth discreetly behind the teeth. This system utilizes patented self-guiding technology to apply continuous forces, allowing for gentle teeth correction while minimizing discomfort and reducing the frequency of dental visits compared to traditional methods. Inbrace aims to enhance patient confidence and satisfaction by addressing common concerns associated with orthodontic treatment. The company incorporates digital treatment planning, computer modeling, and direct digital manufacturing to provide a scalable, personalized solution that meets the diverse needs of orthodontic patients. With its FDA registration, Inbrace is positioned to disrupt the orthodontics market and drive practice growth for dental clinicians.

Divergent Technologies, Inc. is a Los Angeles-based company that specializes in the development and manufacturing of 3D printed vehicles. Incorporated in 2014, Divergent has pioneered the Divergent Adaptive Production System (DAPS™), an innovative software-hardware platform designed to revolutionize industrial digital manufacturing. This system enables customers to design, additively manufacture, and automatically assemble complex structures for a variety of applications, including automotive, aerospace, and defense. By optimizing designs and dematerializing structures, DAPS significantly enhances manufacturing efficiency while reducing waste and environmental impact. The company's approach eliminates the need for traditional tooling, facilitating radical innovation and capital reduction in vehicle manufacturing.

Soli Organic is an indoor farming startup that specializes in providing fresh organic culinary herbs to grocery stores, ensuring a year-round supply for consumers. The company's offerings include a variety of herbs such as basil, rosemary, lime leaves, chives, and arugula, all cultivated as living plants with fresh-cut leaves. Soli Organic focuses on delivering healthy and flavorful products that promote local consumption and enhance culinary experiences. By growing these herbs regionally, the company aims to make fresh organic options accessible to millions, thereby contributing to a more flavorful and sustainable food culture.

Secure Transfusion Services is a life sciences company that aims to improve the quality and availability of transfusable blood components. The company is dedicated to helping the blood industry modernize and stabilize by enhancing the vital role that nonprofit blood banks play in ensuring the nation's blood supply.

Aerobiotix is a privately held company focused on creating and producing proprietary environmental management devices designed for institutional healthcare, home health, and commercial applications. The company specializes in innovative technologies aimed at efficiently eliminating airborne viruses, bacteria, and spores, thereby optimizing indoor environments. By addressing critical health concerns related to air quality, Aerobiotix provides solutions that enhance safety and well-being in various settings.

Interior Define Inc. is a furniture design and manufacturing company headquartered in Chicago, Illinois, founded in 2013. It specializes in customizable furniture products, including sofas, occasional chairs, chaise lounges, and sectionals. By employing a made-to-order production approach, Interior Define allows customers to personalize their furniture according to various factors such as size, configuration, fabric, and leg style, creating a high-quality, tailored experience akin to luxury brands but at more accessible prices. The company operates through both online platforms and physical showrooms, known as Guideshops, located in major cities like New York, San Francisco, and Los Angeles. Customers can explore products in a 360-degree view online, order free fabric swatches, and utilize an augmented reality app to visualize furniture in their own homes. Interior Define also emphasizes customer service with complimentary white glove delivery and a standard 365-day return policy, enhancing the overall shopping experience.

IMV Inc., headquartered in Dartmouth, Canada, is a clinical-stage biopharmaceutical company focused on developing cancer immunotherapies and vaccines against infectious diseases. Founded in 2000, the company utilizes its proprietary delivery platform (DPX) to directly program immune cells within the body, enhancing their ability to target and eliminate specific threats. IMV's lead drug candidate, DPX-Survivac, is a targeted T cell therapy that has shown promising results in late-stage ovarian cancer and relapsed/refractory DLBCL, with multiple Phase 2 clinical trials ongoing across six cancer indications. Additionally, the company is developing a DPX-based vaccine candidate against COVID-19 and DPX-RSV, targeting the respiratory syncytial virus strain A. IMV collaborates with infectious disease experts and has partnerships in the animal health sector, including an agreement with Pfizer Animal Health.

Everstream Analytics is a supply chain risk analytics company focused on enhancing the resilience and agility of clients' supply chains. By integrating with procurement, logistics, and business continuity platforms, the company provides comprehensive global visibility of supply chain risks. Utilizing data science, proprietary intelligence, and a team of multilingual specialists, Everstream Analytics monitors global risks and events in real-time, allowing clients to respond proactively. Its platform tracks risk alongside business performance indicators, builds detailed risk profiles, and identifies critical hotspots through heat maps. This approach enables businesses to effectively visualize and manage potential disruptions, ensuring continuity and transforming risks into competitive advantages.

Stealth BioTherapeutics is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of innovative therapies targeting diseases associated with mitochondrial dysfunction. Founded in 2006 and headquartered in George Town, the Cayman Islands, the company’s lead product candidate, Elamipretide, aims to address both rare genetic and common age-related mitochondrial diseases. Additionally, Stealth BioTherapeutics is developing SBT-20, a small peptide designed to stabilize mitochondrial structure and function under oxidative stress, and SBT-272, which is being evaluated for its potential in treating rare neurodegenerative disorders, including amyotrophic lateral sclerosis. By focusing on mitochondrial health, Stealth BioTherapeutics seeks to improve outcomes for patients suffering from these challenging conditions.

Nogin is a software company specializing in commerce solutions for brands in fashion, CPG, beauty, health, and wellness sectors. It offers an Intelligent Commerce platform, a cloud-based e-commerce environment that enables brands to manage their online sales and operations efficiently. The platform provides a range of services, including storefront creation, order management, catalog maintenance, fulfillment, returns management, customer data analytics, and marketing optimization. Clients use Nogin's technology to drive growth in gross merchandise value, enhance customer engagement, and reduce costs. The company generates revenue through its Commerce-as-a-Service (CaaS) model and product sales.

Embody, Inc., established in 2014 and based in Norfolk, Virginia, is a regenerative medicine company specializing in the development and commercialization of implantable medical devices. The company focuses on addressing unmet demands in soft tissue restoration and regeneration, with a particular emphasis on tendon and ligament repair. Embody's innovative collagen-based microfiber implants are designed to replicate the biological and biomechanical properties of native tissue, aiming to restore pre-injury performance for a wide range of patients, including warfighters, athletes, and those suffering from sports injuries. The company's technology, which includes microfluidic biofabrication and electrospinning, enables it to create advanced biomaterial-based devices that enhance healthcare providers' ability to repair and regenerate damaged soft tissue.

Embody, Inc., established in 2014 and based in Norfolk, Virginia, is a regenerative medicine company specializing in the development and commercialization of implantable medical devices. The company focuses on addressing unmet demands in soft tissue restoration and regeneration, with a particular emphasis on tendon and ligament repair. Embody's innovative collagen-based microfiber implants are designed to replicate the biological and biomechanical properties of native tissue, aiming to restore pre-injury performance for a wide range of patients, including warfighters, athletes, and those suffering from sports injuries. The company's technology, which includes microfluidic biofabrication and electrospinning, enables it to create advanced biomaterial-based devices that enhance healthcare providers' ability to repair and regenerate damaged soft tissue.

Cerecor Inc. is a biopharmaceutical company dedicated to the development and commercialization of treatments for rare pediatric and orphan diseases. Founded in 2011 and headquartered in Rockville, Maryland, the company is advancing a clinical-stage pipeline that includes therapies for inherited metabolic disorders, such as CERC-801, CERC-802, and CERC-803, which are focused on congenital disorders of glycosylation. Additionally, Cerecor is developing CERC-006, an oral mTOR inhibitor aimed at treating complex lymphatic malformations, and two monoclonal antibodies: CERC-002, targeting the cytokine LIGHT for severe pediatric-onset Crohn's disease, and CERC-007, targeting IL-18 for autoimmune inflammatory diseases like adult onset Still's disease and multiple myeloma. Several of these therapies have received Orphan Drug Designation and Rare Pediatric Disease Designation, qualifying them for expedited review upon FDA approval. Cerecor also offers Millipred, an oral prednisolone for various inflammatory conditions.

RepTrak is the creator of an enterprise software platform and subscription-based service that helps businesses understand, improve, and protect their corporate reputation through key data analytics. Its proprietary RepTrak model is the global standard for measuring and analyzing global sentiment across industries and geographies, using proven data science models and machine learning techniques. The RepTrak Company, founded in 2004, owns a large reputation benchmarking database of over 1 million company ratings per year, which is used by CEOs, boards, and executives in over 60 countries worldwide.

LiquiGlide Inc., founded in 2012 and based in Cambridge, Massachusetts, specializes in the development of innovative liquid-impregnated coatings designed to facilitate the effortless movement of viscous liquids. As a pioneer in creating permanently wet slippery surfaces, LiquiGlide provides unique solutions that enhance the flow of liquids across various industries, including manufacturing, oil and gas, aviation, utilities, and food and beverage. The company's technology addresses the common challenges associated with moving thick liquids, offering a durable alternative that is unmatched in the market. LiquiGlide's products are utilized in diverse applications, ranging from health and beauty to household goods, making it a versatile player in the coatings industry.

Cerecor Inc. is a biopharmaceutical company dedicated to the development and commercialization of treatments for rare pediatric and orphan diseases. Founded in 2011 and headquartered in Rockville, Maryland, the company is advancing a clinical-stage pipeline that includes therapies for inherited metabolic disorders, such as CERC-801, CERC-802, and CERC-803, which are focused on congenital disorders of glycosylation. Additionally, Cerecor is developing CERC-006, an oral mTOR inhibitor aimed at treating complex lymphatic malformations, and two monoclonal antibodies: CERC-002, targeting the cytokine LIGHT for severe pediatric-onset Crohn's disease, and CERC-007, targeting IL-18 for autoimmune inflammatory diseases like adult onset Still's disease and multiple myeloma. Several of these therapies have received Orphan Drug Designation and Rare Pediatric Disease Designation, qualifying them for expedited review upon FDA approval. Cerecor also offers Millipred, an oral prednisolone for various inflammatory conditions.

Launched in 2016, Fingerlix is the brainchild of 4 foodies. Their purpose is to spread Joy through food by easing up cooking and exploration. They believe that Joy stems from spending more time with family and less time in the kitchen. Joy is maximum when they discover something new and different that entices their taste buds. Joy also comes from making healthier, happier food choices that leave us with a feeling of goodness. Through their Ready-to-Cook & Ready-to-Eat food options, they want to be a part of your cooking journey, partnering you, everyday - day after day. And they do their best to make that happen – sourcing choicest ingredients, maintaining extremely high hygiene standards and above all, inspiring your magical touch to transform every dish into ‘Your dish’.

Alula Holdings, LLC is a smart security company headquartered in Hudson, Wisconsin, that specializes in developing an integrated security platform for security dealers and installers. Founded in 2018, the company offers a comprehensive solution that encompasses security, alarm, video, and automation services tailored for renters, homeowners, and commercial installations. Alula's platform is designed to simplify security for independent dealers and their customers, providing low-cost, Internet-based interactive alarm systems and connected property products. By delivering differentiated security and automation solutions, Alula enables professional alarm dealers and integrators to enhance their business profitability while offering a consistent management experience. The company focuses on empowering its partners with technology-rich solutions that showcase their brand effectively.

IDbyDNA, Inc. is a biotechnology company focused on developing metagenomics technologies for the precise identification of infectious diseases. Founded in 2014 and based in Salt Lake City, Utah, the company offers its proprietary platform, Explify, which aids laboratories in detecting pathogens through a streamlined workflow. IDbyDNA provides a range of testing services, including respiratory and research services, primarily catering to hospitals, reference labs, clinical research organizations, and the biopharmaceutical industry. By integrating computational biology and artificial intelligence into its offerings, the company enhances the accuracy of nucleic acid-based microorganism detection, enabling healthcare providers to deliver comprehensive infectious disease profiles. IDbyDNA aims to improve diagnostic and treatment practices in response to the growing challenge of infectious diseases, thereby reducing related morbidity and mortality.

Corinth MedTech, Inc. is a medical technology company based in Cupertino, California, specializing in the manufacture of innovative disposable bipolar transurethral and transcervical resectoscopes. Established in 2011, the company has developed systems designed for endoscopically controlled tissue removal, primarily targeting male patients with benign prostatic hyperplasia (BPH) and female patients facing issues such as abnormal uterine bleeding, fibroids, or polyps. Corinth MedTech's proprietary bipolar resecting devices enable medical professionals to perform effective and precise procedures, facilitating the treatment of enlarged prostates and, potentially, bladder tumors. The company aims to improve patient outcomes through its advanced technology in urology and gynecology.

Sonex Health, LLC, founded in 2014 and based in Rochester, Minnesota, specializes in developing micro-invasive surgical devices aimed at enhancing patient outcomes in orthopedic care. The company’s flagship product, the SX-One MicroKnife with Meerkat Technology, is designed for the ultrasound-guided treatment of carpal tunnel syndrome through a procedure known as Micro-invasive Carpal Tunnel Release. This innovative approach allows the surgery to be performed in a surgery center or office setting rather than a traditional operating room, resulting in quicker recovery times, improved cosmetic results, and reduced healthcare costs. The SX-One MicroKnife features an ultra-low-profile design that enables the procedure via a single micro-incision, which is significantly smaller than those used in conventional surgeries. This minimally invasive technique not only reduces surgical trauma but also facilitates a faster return to daily activities for patients, as immobilization is often unnecessary, allowing for immediate rehabilitation. Overall, Sonex Health is committed to advancing surgical methods that prioritize patient safety and cost-effectiveness.

Getaround, Inc. is an online marketplace specializing in peer-to-peer car sharing and local car rentals. Founded in 2009 and based in San Francisco, California, Getaround allows users to rent vehicles on-demand, ranging from economy cars to luxury models, by the hour or day. The platform facilitates a seamless experience through its patented Getaround Connect technology, which enables users to access cars without needing to meet the vehicle owner or handle physical keys. This innovative approach eliminates the traditional hassles of car rental, such as long lines and paperwork. Getaround operates in several major U.S. cities, including San Francisco, San Diego, Chicago, and Washington, D.C., providing a convenient and eco-friendly alternative to car ownership while allowing vehicle owners to earn extra income. The service also includes comprehensive insurance and 24/7 roadside assistance, ensuring a safe and enjoyable experience for users.

Topia Limited is a provider of mobility management solutions that focuses on global talent mobility for businesses. Established in 2010 and headquartered in London, with an additional office in San Francisco, Topia offers a comprehensive platform that streamlines the entire talent mobility process. This includes relocation and expatriate administration, tax and immigration management, and payroll calculations. The company’s platform, known as Topia One, is a cloud-based system that integrates data standards across global talent mobility. Additionally, the Topia Go mobile application allows employees to manage their relocations and assignments effectively. Topia serves a diverse clientele, including well-known brands such as Dell, Schneider Electric, and Deliveroo, and has established strategic partnerships with organizations like Fragomen Worldwide and the Employee Mobility Institute. The company was previously known as MOVE Guides Limited until its rebranding in April 2018.

Emalex Biosciences is a biotechnology startup focused on developing innovative treatments for central nervous system (CNS) disorders and rare neurological conditions. Founded in 2018 by Jeff Aronin, the company is advancing its lead candidate, Ecopipam, which has been explored as a potential therapy for various CNS disorders, including pediatric Tourette Syndrome and fluency disorders. Emalex aims to address the needs of patients with rare diseases that currently have limited or no treatment options, collaborating with patient advocacy organizations and medical researchers to facilitate the development of effective biopharmaceutical therapies.

Magnolia Medical Technologies, Inc. is a medical device company based in Seattle, Washington, focused on enhancing the accuracy of diagnostic blood culture tests. Established in 2011, the company has developed SteriPath, a vacuum-assisted blood collection system designed to prevent contamination of blood samples, which can lead to misdiagnosis of sepsis. This innovative system operates by actively diverting and sequestering contaminated blood, allowing for the collection of uncontaminated samples through a separate flow path. This closed vein-to-bottle collection method aims to improve diagnostic specimen quality, thereby increasing diagnostic accuracy and improving patient outcomes. Magnolia Medical Technologies holds a robust intellectual property portfolio, including over 70 issued patents and more than 50 pending applications, reflecting its commitment to advancing medical technology and addressing challenges such as antibiotic resistance. The company's products are distributed throughout the United States.

Ceribell, Inc. is a medical technology company based in Mountain View, California, that specializes in the design and manufacture of devices for acquiring and interpreting electroencephalography (EEG) data. Founded in 2014, Ceribell focuses on making EEG technology more accessible, efficient, and cost-effective, particularly in acute care settings. The company's flagship product, the Ceribell EEG System, includes a portable EEG headband and a compact recorder that provide clinical-quality EEG results without the need for a trained EEG technologist. This system can be set up by healthcare providers in just six minutes, facilitating quicker clinical decision-making. An innovative feature of the Ceribell System is its Brain Stethoscope function, which translates brainwave patterns into sound to aid in the detection of seizures, including non-convulsive seizures. This capability enables earlier diagnosis and targeted treatment, potentially reducing mortality, length of hospital stays, and the risk of complications for patients with serious neurological conditions.

Castle Creek Biosciences, Inc. is a gene therapy company headquartered in Exton, Pennsylvania, that specializes in developing and commercializing personalized gene therapies for rare skin and connective tissue disorders. Founded in 2015, the company utilizes a fibroblast technology platform that extracts fibroblast cells from a patient's own skin to create localized therapies tailored to the individual’s unique biology. This innovative approach aims to address the underlying causes of diseases that currently have high unmet medical needs, ultimately improving the lives of patients suffering from these underserved conditions.

OutboundEngine, Inc. is a marketing technology company based in Austin, Texas, that specializes in providing marketing automation solutions for small and midsize businesses across various sectors, including real estate, finance, insurance, and wellness. Founded in 2010, the company offers a cloud-based platform that simplifies online marketing by automating email campaigns, social media postings, and online review collection. This platform, known as The OutboundEngine Platform, enables clients to deliver personalized marketing content efficiently and effectively. In addition to its core offerings, OutboundEngine provides a tool called Harmony, which facilitates unified marketing across franchise and agent networks. The company has established itself as a leader in the marketing automation space, serving over 10,000 customers and earning recognition as a top workplace in Austin.

Meditrina, Inc. is a medical device company based in San Jose, California, established in 2016. The company specializes in developing innovative tissue removal solutions specifically designed for intrauterine pathology. Its flagship product, the Aveta System, serves healthcare professionals by providing an all-in-one solution for hysteroscopic diagnostic and therapeutic procedures, such as the removal of polyps and fibroids. The Aveta System is notable for its compact design, which allows for seamless integration into various clinical settings, including offices and operating rooms. It features advanced capabilities such as wide-angle HD hysteroscopy, improved fluid management for better pressure control, and a small insertion diameter coupled with a large working channel, all of which contribute to optimized tissue resection and enhanced procedural efficiency.

Encore Dermatology is a privately held, fully-integrated dermatology company based in Malvern, Pennsylvania, established in 2015. The company specializes in delivering prescription therapies and medical devices to dermatologists, focusing on a variety of medical dermatology products. These offerings address several topical disease states, including conditions like acne and atopic dermatitis, thereby facilitating enhanced skincare and treatment options for patients. Through its comprehensive approach, Encore Dermatology aims to improve patient outcomes and streamline the dermatological care process.

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative cell and gene therapies aimed at curing hematologic cancers, solid tumors, and rare genetic diseases. The company’s pipeline includes gene therapy programs for rare genetic disorders and chimeric antigen receptor (CAR) T cell therapies targeting various malignancies. Notable developments include MB-107, a potential curative gene therapy for X-linked severe combined immunodeficiency, and several CAR T therapies such as MB-102 for acute myeloid leukemia, MB-106 for B-cell lymphomas, and programs targeting glioblastoma and solid tumors like breast and pancreatic cancers. Mustang Bio has established collaborations with institutions such as Nationwide Children’s Hospital and Beth Israel Deaconess Medical Center to advance its research initiatives. Founded in 2015 and headquartered in New York, the company operates as a subsidiary of Fortress Biotech, Inc.

CSA Medical, Inc., established in 1993 and headquartered in Baltimore, Maryland, specializes in the development and manufacturing of spray cryotherapy medical devices. Its primary product, truFreeze, utilizes cold liquid nitrogen to destroy unwanted tissue across dermatology, gynecology, and general surgery fields while promoting healthy tissue regrowth. CSA Medical also offers the Rapid AV Spray Kit to enhance truFreeze's efficiency. The company operates a research and development facility in Lexington, Massachusetts.

MacuLogix, Inc. is a company specializing in the diagnosis, monitoring, and treatment of age-related macular degeneration (AMD), a leading cause of blindness. The company develops innovative tools, including the AdaptDx, a fully automated dark adaptometer that allows eye care professionals to assess the dark adaptation process in patients. This technology enables early detection and tracking of AMD, allowing for intervention up to three years before the disease manifests visually. MacuLogix aims to reduce preventable blindness through its screening tools, which are distributed across the United States and internationally, as well as sold online. Founded in 2008 and based in Harrisburg, Pennsylvania, MacuLogix continues to advance its mission to combat vision loss associated with AMD.

New Signature is a cloud-first, full-service Microsoft technology partner that provides comprehensive technology services to businesses of all sizes and industries. The company focuses on solving complex business challenges by leveraging Microsoft solutions, employing a process-driven approach that ensures consistent success for its clients. New Signature assists organizations in making informed investment decisions through thorough economic analysis, highlighting the value of Microsoft offerings. Their expertise encompasses planning, designing, deploying, customizing, managing, and supporting Microsoft services, with an emphasis on delivering maximum return on investment. Additionally, the company offers tailored user adoption and learning solutions aimed at enhancing the proficiency of both business users and IT professionals.

Ontrak is an AI-powered and technology-enabled behavioral healthcare company focused on improving health outcomes for individuals with behavioral conditions that lead to chronic medical issues. The company offers specialized health management services through a network of licensed providers, utilizing claim-based analytics and predictive modeling to deliver personalized care programs. Ontrak's integrated solutions combine medical and psychosocial interventions with long-term care coaching and online tools to support members in their recovery from substance dependence and other behavioral health challenges.

Since 2003, we help companies driving digital innovation, with disruptive methodologies. We design new brands, new services and new products, in collaboration with our clients and their partners. We assist large groups, start-ups and SMEs in the conduct of disruption (Disrupt), of digital experience design (Design), and the conduct of growth (Scale). Our approach is different from a digital agency: we are structured as a consultancy, with concrete execution abilities in design and in marketing.

Audacy is a space communications service provider enabling continuous satellite and launch vehicle connectivity from the launchpad to the Moon. Its mission is to deliver anytime, highly operable connectivity that advances humankind to an unparalleled age of space exploration and discovery. The company was founded in 2015 and headquartered in Mountain View, California.

IntelePeer is a communications automation platform that utilizes generative AI to enhance customer interactions for businesses. By offering a cloud-based Communications Platform as a Service (CPaaS), the company provides on-demand IP communications and SIP trunking services tailored for enterprises. IntelePeer's platform integrates seamlessly with existing systems, allowing businesses to streamline their communication processes across multiple channels. Its focus on automation not only reduces operational costs but also improves customer experience by delivering efficient and effective communication solutions. The incorporation of AI and analytics further enhances the platform's capabilities, enabling clients to achieve higher levels of customer satisfaction and engagement.

Conventus Orthopaedics provides a range of orthopedic and sports medicine services. The physicians specialize in orthopedic surgery, reconstructive surgery, spine surgery, joint replacement, sports medicine, physical therapy, and operative care of fractures, arthritis, strains, sprains, and sports-related injuries. Conventus was formed by a team of medical professionals with the sole purpose of creating less invasive ways to treat challenging periarticular fractures. By leveraging advanced nitinol technology, the Conventus team has developed a platform technology that provides robust fixation and creates reliable repairs. The company was incorporated in 2009 and is based in Maple Grove, Minnesota.

Aerin Medical Inc. is a health technology company based in Sunnyvale, California, specializing in non-invasive treatment solutions for nasal breathing disorders. Founded in 2011, the company develops therapeutic devices that utilize low-power radiofrequency energy to remodel nasal soft tissues, addressing underlying causes of conditions like nasal obstruction and chronic rhinitis. Its flagship products include the VivAer procedure and device for nasal airway obstruction, as well as the RhinAer procedure and device for chronic rhinitis. These innovative offerings enable ENT physicians to provide effective treatments in an office setting, often with local anesthesia and little to no downtime for patients, making them appealing alternatives to traditional invasive surgeries.

Titan Pharmaceuticals, Inc. is a biopharmaceutical company based in South San Francisco, California, focused on developing proprietary therapeutics for chronic diseases. The company utilizes its innovative ProNeura technology, a long-term drug delivery platform, to create products that maintain stable blood levels of medication over extended periods. Titan's principal product, Probuphine, is the first slow-release implant formulation of buprenorphine, designed for the outpatient treatment of opioid dependence. This implant allows for consistent medication delivery for up to six months, enhancing patient compliance and reducing the risk of misuse associated with traditional sublingual formulations. Additionally, Titan is developing ProNeura-Ropinirole, an implant for treating Parkinson’s disease, and a triiodothyronine implant for hypothyroidism. Established in 1992, Titan is committed to addressing serious medical disorders through its advanced drug delivery solutions.

PebblePost Inc., established in 2014 and headquartered in New York, specializes in a direct mail marketing platform that bridges digital intent with physical mail. The company pioneered Programmatic Direct Mail, leveraging real-time online activity data to send targeted direct mail pieces, enhancing buying decisions at home and driving conversions across various channels. PebblePost's platform offers advanced targeting, algorithmic optimization, attribution analysis, and campaign management tools for marketers to engage consumers effectively.

IgnitionOne, established in 2004, specializes in cloud-based digital marketing software. It offers a unified customer intelligence platform that enables enterprise marketers to consolidate customer data, gain insights, and engage audiences across channels. The platform provides solutions for data management, analytics, creative asset management, and search management, along with website personalization and email optimization tools. IgnitionOne empowers marketers to make data-driven decisions, maximizing overall marketing results.

Strongbridge Biopharma plc is a commercial-stage biopharmaceutical company dedicated to developing and commercializing therapies for rare diseases with significant unmet medical needs. The company’s primary focus is on rare endocrine disorders, exemplified by its product candidates, Recorlev, a cortisol synthesis inhibitor currently in Phase III trials for endogenous Cushing's syndrome, and Veldoreotide, a somatostatin analog that has completed Phase II trials for acromegaly. Strongbridge also offers Keveyis, an oral carbonic anhydrase inhibitor approved for treating specific forms of periodic paralysis in the United States. Founded in 1996 and headquartered in Trevose, Pennsylvania, the company aims to leverage a concentrated prescriber base for its products and plans to utilize a targeted sales force for marketing in the U.S., European Union, and other key markets. Additionally, Strongbridge seeks to enhance its portfolio through the in-licensing or acquisition of complementary products that align with its focus on rare endocrine conditions.

Receptiv, founded in 2011 as MediaBrix and rebranded in 2017, is a New York-based company that operates as a subsidiary of Verve Wireless. It specializes in developing a mobile video advertising platform, offering both programmatic and managed services to create brand engagements for advertisers and publishers. Receptiv's unique approach combines emotional targeting with precise audience intelligence via Motiv, its proprietary first-party data management platform. This enables the company to deliver contextualized ads during meaningful moments across over 1,300 premium apps, serving leading brands such as Mars, Coca-Cola, and Microsoft. Backed by investors including Edison Partners and Revel Partners, Receptiv has been recognized as an Adweek Top Mobile Innovator.

ScoreBig, Inc. is an online platform that allows consumers to purchase tickets for various live events, including sports, concerts, and theater performances, often at significant discounts of up to 60%. Founded in 2009 and headquartered in Hollywood, California, ScoreBig specializes in selling a limited number of tickets per event, thus maintaining an opaque sales channel that helps event organizers sell unsold seats without undercutting their pricing strategies. The company serves as a marketplace for venue operators, sports teams, and arts organizations, enabling them to move excess inventory while preserving the perceived value of their tickets. With a focus on providing savings for fans and facilitating ticket sales for event organizers, ScoreBig has established itself as a prominent player in the live event ticketing industry.

Avalanche Technology, Inc. is a technology company headquartered in Fremont, California, specializing in the development and marketing of non-volatile spin transfer torque magnetic random access memory devices. Founded in 2006, the company focuses on creating high-performance memory solutions for various applications, including mobile devices, the Internet of Things, enterprise storage, computing, networking, telecommunications, and automotive industries. Avalanche Technology's innovative products aim to replace traditional memory technologies such as static random access memory, flash, and read-only memory, providing enhanced speed, endurance, and power efficiency. The company holds a substantial portfolio of over 200 patents related to memory cell design, circuitry, and system processes, positioning it as a leader in the field of advanced memory technology.

Nomi is an omni-channel marketing platform designed to enhance customer engagement for retailers. By analyzing and optimizing the return on investment from offline marketing and store operations, Nomi quantifies the effectiveness of marketing campaigns in driving foot traffic and assesses customer lifetime value. The platform helps retailers evaluate how well stores convert visitors into buyers, identify underperforming staff, and measure the impact of training and management investments on customer behavior. Nomi offers a comprehensive view of the customer conversion funnel, enabling retailers to predict store performance and diagnose operational issues proactively. Founded in September 2012 by Marc Ferrentino, Corey Capasso, Wesley Barrow, Peter Quintas, and Robert Balousek, the company is headquartered in New York, United States.

Digital Signal is a company based in Chantilly, Virginia, that specializes in three-dimensional long-range facial recognition technology tailored for both government and commercial sectors. Founded in 2001, it develops LIDAR-based solutions capable of identifying non-cooperative individuals and recognizing faces within crowded environments at extended distances. The company's technology offers a comprehensive identity intelligence system, encompassing enrollment, monitoring, and identity analytics. By leveraging the precision of 3D facial scanning, Digital Signal enables accurate identification of subjects in motion and those with off-angle poses, even through sunglasses, ensuring high levels of biometric accuracy for surveillance applications.

New Haven Pharmaceuticals (NHP) is a specialty pharmaceuticals company focused on developing proprietary prescription medications that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs). The company aims to address significant therapeutic needs by offering innovative, controlled-release formulations that enhance dosing precision, safety, efficacy, and patient convenience. NHP's product pipeline leverages proprietary technologies and intellectual property licensed from Yale University, allowing the development of specialty drugs for new therapeutic indications. Through its innovative platform, NHP seeks to provide premium pharmaceutical solutions that meet the evolving needs of patients and healthcare providers.

Bridge2 Solutions, Inc. is a marketing solutions provider that specializes in enhancing consumer engagement and loyalty for financial institutions, retailers, loyalty programs, and Fortune 500 companies. Established in 2006 and headquartered in Alpharetta, Georgia, with additional locations in Scottsdale, Arizona, and Chennai, India, the company operates a cloud-based platform that facilitates incentive, consumer, and performance rewards. This platform connects loyalty program sponsors with a diverse range of retail, merchant, and travel brands, streamlining the reward fulfillment process by eliminating the need for physical inventory. Bridge2 Solutions offers a suite of services including customer support, account management, and professional services, all aimed at driving customer loyalty and engagement across various industries.

Medsphere Systems Corporation is a healthcare information technology company based in Carlsbad, California, founded in 2002. It specializes in providing open-source software solutions, notably through its OpenVista platform, which offers a comprehensive electronic health record system. This platform supports various healthcare functions, including clinical, financial, patient accounting, laboratory, pharmacy, radiology, and nutrition services. Medsphere also delivers a range of professional services, such as implementation, training, support, and system integration to enhance operational efficiency in hospitals, clinics, and integrated delivery networks. The company's solutions are designed to streamline clinical workflows and improve patient care while ensuring interoperability across different healthcare systems. Medsphere serves a diverse clientele, including critical access hospitals, acute care facilities, behavioral health centers, and government entities.

SilkRoad Technology, Inc. is a provider of cloud-based talent management solutions that cater to organizations in the United States and around the globe. Founded in 2003 and headquartered in Chicago, Illinois, the company offers a comprehensive suite of products designed to enhance various aspects of human resource management. Its offerings include talent acquisition tools, employee onboarding software, performance management solutions, and a human resource management system that allows for effective management of employee and organizational data. SilkRoad's platforms, such as SilkRoad Recruiting and SilkRoad Learning, facilitate recruitment through social channels and support social learning and content management. Additionally, the company provides consulting, implementation, and training services to ensure clients can effectively utilize its solutions. SilkRoad Technology serves a diverse range of industries, including financial services, healthcare, higher education, and retail, with a commitment to helping organizations attract, retain, and engage their workforce in a rapidly evolving business environment.

SavingStar, Inc. is a cash back rewards platform focusing on grocery and online shopping. Founded in 2010 and based in Waltham, Massachusetts, the company allows users to earn cash back on grocery purchases by linking offers to their supermarket and drugstore loyalty cards, as well as by submitting receipt images. This paperless system eliminates the need for traditional coupons, making it easier for shoppers to redeem rewards. In addition to grocery offers, SavingStar provides incentives for online shopping at various retailers, enabling users to earn double cash back on purchases made through its platform. The company also facilitates brand promotions, allowing for engagement through activities such as watching videos or sharing contact information. SavingStar operates as a subsidiary of Quotient Technology Inc.

ScoreBig, Inc. is an online platform that allows consumers to purchase tickets for various live events, including sports, concerts, and theater performances, often at significant discounts of up to 60%. Founded in 2009 and headquartered in Hollywood, California, ScoreBig specializes in selling a limited number of tickets per event, thus maintaining an opaque sales channel that helps event organizers sell unsold seats without undercutting their pricing strategies. The company serves as a marketplace for venue operators, sports teams, and arts organizations, enabling them to move excess inventory while preserving the perceived value of their tickets. With a focus on providing savings for fans and facilitating ticket sales for event organizers, ScoreBig has established itself as a prominent player in the live event ticketing industry.

NinePoint Medical, Inc. is a medical device company based in Bedford, Massachusetts, that specializes in the development of innovative optical coherence tomography (OCT) imaging systems for assessing human tissue microstructure. The company's flagship product, the NvisionVLE Imaging System, enables real-time volumetric imaging of the esophagus and bile duct, allowing physicians across various specialties—including gastroenterology, pulmonology, urology, gynecology, and ENT—to perform advanced diagnostic procedures. By providing high-resolution cross-sectional images, NinePoint's system empowers physicians to make accurate diagnoses and implement effective therapies during the same procedure, enhancing patient care and outcomes. The company markets its imaging systems through a network of distributors in the United States and internationally. Originally founded as Convergence Devices, Inc. in 2008, NinePoint Medical underwent a name change in 2009 and has since focused on advancing telepathology capabilities to improve healthcare efficiency and patient experiences.

Palatin Technologies, Inc. is a biopharmaceutical company focused on developing targeted, receptor-specific peptide therapeutics to address diseases with significant unmet medical needs. Based in Cranbury, New Jersey, the company’s lead product is Vyleesi, a melanocortin receptor agonist aimed at treating premenopausal women with acquired, generalized hypoactive sexual desire disorder. In addition to Vyleesi, Palatin is advancing several other drug candidates, including oral PL8177 and systemic PL8177 for inflammatory bowel diseases and non-infectious uveitis, respectively. The company also develops PL9643 for ocular inflammatory conditions, PL3994 for cardiovascular issues, and PL5028 for cardiovascular and fibrotic diseases. Palatin's research emphasizes receptor-selective melanocortin agonists, which activate endogenous pathways to mitigate inflammation and promote tissue healing in various disease models, particularly in ocular and intestinal applications.

Interleukin Genetics, Inc. is a company specializing in personalized health through the development of genetic tests aimed at enhancing individual wellness. The organization focuses on two primary areas: the provision of genetic test products for personal health improvement and research and development efforts that create tests linked to partners’ products for medical and dental markets. Their genetic testing technology provides clear insights into wellness, offering personalized guidance on diet and exercise choices, which empowers individuals to take proactive steps in managing their health. Through partnerships and direct sales channels, Interleukin Genetics aims to contribute to the growing personalized health market by enabling individuals to make informed decisions about their health and wellness.

ZetrOZ, LLC is a manufacturer based in Trumbull, Connecticut, specializing in advanced ultrasound technology. Founded in 2009, the company focuses on developing non-invasive medical devices aimed at tissue healing and pain relief for chronic musculoskeletal conditions. ZetrOZ offers a range of products, including the UltrOZ Elite therapeutic systems, wearable veterinary ultrasound systems, and high intensity focused ultrasound systems tailored for biomedical research and industrial applications. Their product lineup also features low-profile ultrasound transducers for therapeutic and diagnostic uses, as well as a variety of applications in industrial monitoring and aquatic environments. The company's innovative generator technology enhances efficiency, portability, and cost-effectiveness, making ultrasound systems more accessible for therapeutic uses such as wound care, surgical procedures, and aesthetic treatments.

InVisage Technologies, Inc. is a fabless semiconductor company headquartered in Menlo Park, California, that specializes in the development of QuantumFilm-based image sensors. Founded in 2005, the company produces advanced imaging technology designed to capture high-fidelity and high-resolution images from mobile devices, including camera phones and digital cameras. InVisage's innovative sensors are capable of absorbing a full spectrum of light, resulting in superior image quality. Their products are utilized across various applications, such as security and surveillance, automotive imaging, military, and medical imaging. InVisage Technologies operates as a subsidiary of Apple Inc. as of November 2017, further enhancing its position in the imaging technology market.

Argos Therapeutics, Inc. was a biotechnology company based in Durham, North Carolina, that specialized in the development of individualized immunotherapies for cancer, infectious diseases, and autoimmune disorders. Founded in 1997 and formerly known as Merix Bioscience, the company utilized its proprietary Arcelis technology platform to create personalized treatments. Its notable product candidates included rocapuldencel-T, which was undergoing Phase III clinical trials for metastatic renal cell carcinoma, and AGS-004, aimed at treating human immunodeficiency virus in Phase II trials. Other investigational products included treatments for transplant rejection and autoimmune diseases. However, Argos Therapeutics filed for Chapter 7 bankruptcy and ceased operations on September 24, 2019.

IntegenX Inc. is a developer of innovative human DNA identification solutions headquartered in Pleasanton, California. Founded in 2003, the company specializes in rapid DNA technology for forensics and law enforcement applications. IntegenX's technology platforms integrate advanced fluidics, optics, biochemistry, and software to create automated sample-to-answer products for human identity testing. The company offers a range of products, including the RapidHIT System, which delivers standardized DNA profiles from various human samples, and the RapidHIT GlobalFiler Express Kit for processing crime scene samples directly within the cartridge. Additionally, IntegenX provides other tools like the Apollo series for DNA sequencing and sample preparation. The company distributes its products in multiple international markets, enhancing capabilities in human identification for law enforcement agencies worldwide.

SpringCM Inc. is a cloud-based document and contract management platform based in Chicago, Illinois, founded in 2005. The company provides solutions that streamline the contract lifecycle, encompassing contract creation, negotiation, approval, signature, archiving, and renewal. Additionally, it offers a digital asset management system that automates processes related to content management, sharing, and collaboration. SpringCM's software enables organizations to efficiently store, organize, and search for documents while facilitating collaboration both internally and externally. The platform is delivered as Software-as-a-Service and includes a mobile application for enhanced accessibility. SpringCM serves various sectors, including legal, IT, operations, sales, human resources, public sector, procurement, and finance. The company also provides consulting, training, and support services to its clients. In 2018, SpringCM became a subsidiary of DocuSign, Inc., and has established a strategic partnership with Salesforce to enhance its service offerings.

MBlox, established in 1999, is a pioneering global mobile messaging company. It maintains over 100 direct carrier relationships and is renowned for its expertise in SMS services. The company's cloud-based platform processes 7 billion mobile messages annually for more than 4,000 clients, ranging from start-ups to multinational corporations. MBlox offers 24/7 email support and customizable support packages to cater to diverse business needs. Its services span various sectors, including financial services, government, transportation, retail, and advertising.

GenePeeks, Inc. is a genetic information company headquartered in New York, New York, that focuses on reducing the risk of heritable diseases through innovative technology. Incorporated in 2009, the company has developed a proprietary software platform that digitally combines the DNA of prospective parents to simulate genetic recombination and reduction. This process generates a comprehensive analysis of potential future children’s genetic profiles, identifying disease risks that existing pre-conception screening methods may overlook. By utilizing Next-Gen sequencing data, GenePeeks creates tens of thousands of virtual genomes, enabling healthcare providers to assess high-risk genetic matches and enhance their understanding of clinically relevant genotypes and variants. The company's mission is to help families safeguard the health of future generations by providing deeper genetic insights.

Social Intelligence Corp., headquartered in Santa Barbara, California, specializes in providing social media data, analytics, tools, and reports to commercial and governmental organizations. The company offers Software as a Service (SaaS) based search tools, predictive scoring algorithms, and proprietary data to deliver comprehensive solutions aimed at reducing costs and enhancing safety. Their unique suite of products includes employment background screenings, insurance claims investigations, corporate due diligence, and government services. Social Intelligence ensures compliance with the Fair Credit Reporting Act (FCRA) and adheres to Federal and State laws. The company's team comprises experts from software, insurance, government services, and employment industries, with founders who have collaborated for over a decade. With a focus on privacy, productivity, and community involvement, Social Intelligence employs over 50 individuals dedicated to providing publicly available online information while ensuring its appropriate and legal use.

AccuVein Inc. is a medical device manufacturer specializing in vein visualization technology to assist healthcare professionals in accessing peripheral veins. Founded in 2006 and based in Medford, New York, the company offers a range of portable, non-contact vein finding devices, including its flagship AV400 system. These products enable practitioners to visualize a map of veins on the skin's surface, thereby improving the accuracy and efficiency of procedures such as blood draws, IV infusions, and cosmetic injections. AccuVein's innovative solutions are utilized across various healthcare settings, including surgery centers, long-term care facilities, and imaging centers. The company markets its products through a network of distributors and sales representatives, both domestically and internationally.

Mederi Therapeutics manufactures and markets innovative medical devices that deliver radiofrequency energy to treat disease states affecting the human digestive system. All Mederi therapies are outpatient, minimally invasive, and promote rapid recovery. Mederi Therapeutics is located in Greenwich, Connecticut.

Inotek Pharmaceuticals is developing molecules with novel mechanisms of action to fulfill major unmet medical needs in significant diseases of the eye. Complete loss of vision or vision impairment currently affects 3.3 million people over the age of 40 in the United States, with the most common diseases including age-related macular degeneration (AMD), glaucoma, cataract and diabetic retinopathy. With the continued aging of the population, the National Eye Institute projects that this number will grow to 5.5 million people by the year 2020.

Overture Networks, Inc. specializes in providing virtualization solutions and high-speed carrier Ethernet edge and aggregation services tailored for carrier-class service providers. Founded in 2000 and headquartered in Morrisville, North Carolina, with additional development offices in Westford, Massachusetts, and Bangalore, India, the company offers a diverse range of products. These include the Overture Orchestrator for cost-effective service delivery, Overture Analytics for actionable intelligence, and various Ethernet access devices that facilitate the transition from traditional TDM infrastructure to modern Ethernet networks. Key offerings also encompass the Overture 65vSE, a carrier-class server, and platforms like the Overture 6500 for performance-assured services across multiple transport mediums. By integrating packet-switched and circuit-switched technologies, Overture Networks delivers adaptable and cost-efficient solutions that cater to various service provider requirements.

Valore is a company dedicated to transforming the textbook industry by addressing its inefficiencies and enhancing access to affordable educational resources. Based in San Diego, Valore operates ValoreBooks.com, a marketplace where college students can buy and sell textbooks at significantly lower prices than those offered by campus bookstores. The platform features a vast selection of titles sourced from over 14,000 booksellers nationwide, often priced up to 90 percent below list price. Valore is recognized for its commitment to providing cost-effective solutions for students while maintaining a high standard of customer service, as evidenced by accolades from the Better Business Bureau. Through these efforts, Valore aims to improve the overall educational experience for students, professors, and educational institutions.

Radisphere National Radiology Group, Inc. offers comprehensive radiology delivery solutions tailored for hospitals and health systems. The company specializes in cloud-based technology solutions, including RadVision and RadPerform, which enhance performance transparency, facilitate benchmarking, and optimize clinical operations. Radisphere's services include on-site radiologist staffing, remote sub-specialist interpretations, and 24/7 care management, allowing health systems to streamline their radiology processes. By centralizing radiology management, Radisphere enables clients to achieve higher quality care while reducing costs and clinical variation. With a client base exceeding 100 across 28 states, Radisphere is committed to transforming radiology practices through measurable performance standards and accountability for diagnostic accuracy and patient care. Founded in 2001 and based in Beachwood, Ohio, Radisphere operates as a subsidiary of Envision Healthcare Corporation.

Enphase Energy, Inc. is a global energy technology company headquartered in Fremont, California, specializing in home energy solutions for the solar photovoltaic industry. Founded in 2006, the company designs, develops, manufactures, and sells innovative products including semiconductor-based microinverters, which convert energy at the individual solar module level, and energy storage systems. Enphase Energy's offerings are complemented by its proprietary networking and software technologies that provide advanced energy monitoring and control services. The company serves a diverse customer base that includes solar distributors, large installers, original equipment manufacturers, and homeowners, facilitating access to its solutions through various channels, including an online store. Additionally, Enphase provides training resources for solar and storage installers and system owners through its Enphase University. By integrating solar generation, storage, and communication on a single platform, Enphase aims to enhance the performance, reliability, and intelligence of solar energy systems, ultimately empowering users to achieve a zero-energy footprint.

Grab Media is a prominent video distribution company that specializes in connecting premium video content with a diverse array of professional sources and well-known advertisers. The company offers digital advertising and video syndication solutions, enabling marketers to effectively reach large, engaged audiences. By hosting, distributing, and monetizing streaming media, Grab Media allows brands to concentrate on promoting their messages while ensuring that their content reaches the right viewers.

Tagged.com was launched in 2004, and is an explosively growing social-networking portal developed specifically for teens aged 13 through 19. Emerging as the premier brand in the lucrative teen demographic, Tagged.com is rapidly becoming the number one teen site on the web.

Revance Therapeutics, Inc. is a biotechnology company that specializes in the development, manufacture, and commercialization of neuromodulators for aesthetic and therapeutic indications. The company's lead product, DaxibotulinumtoxinA for injection (DAXI), is undergoing various stages of clinical trials for treatments including glabellar lines, cervical dystonia, adult upper limb spasticity, plantar fasciitis, and chronic migraine. Revance is also advancing DAXI for aesthetic applications such as forehead lines and lateral canthal lines. Additionally, the company is developing DaxibotulinumtoxinA Topical for both therapeutic and aesthetic uses, alongside a biosimilar formulation akin to BOTOX. Revance has established collaboration agreements for the development and commercialization of its biosimilar products. Founded in 1999 and headquartered in Newark, California, Revance was previously known as Essentia Biosystems, Inc., having rebranded in 2005. The company is committed to enhancing its portfolio in dermatology and aesthetic medicine, including a range of dermal fillers and a platform for aesthetic services.

Ambit Biosciences is a privately-held biopharmaceutical company that specializes in the discovery and development of small molecule kinase inhibitors aimed at treating cancer and inflammatory diseases. The company's lead compound, AC220, is a selective and orally bioavailable inhibitor of FMS-like tyrosine kinase-3 (FLT3), currently undergoing clinical trials for patients with relapsed or refractory acute myeloid leukemia (AML). Ambit is collaborating with Astellas Pharma Inc. to jointly develop and commercialize FLT3 kinase inhibitors across various therapeutic areas. In addition to AC220, Ambit's clinical pipeline features AC480, a pan-HER inhibitor, and AC430, an oral inhibitor of JAK2. Furthermore, the company has several preclinical candidates, including CEP-32496, a BRAF inhibitor that is licensed to Cephalon. Through its innovative approach, Ambit aims to enhance treatment outcomes for cancer patients.

COPAN Systems, Inc. is a technology company based in Longmont, Colorado, founded in 2002. The company specializes in providing a comprehensive range of idle disk storage solutions designed to maximize the value of long-term persistent data. Its product offerings include virtual tape libraries for backup and disaster recovery, as well as archiving solutions that enable the retention and retrieval of digital assets at the file level. In addition to these core products, COPAN Systems delivers services related to data protection, tiered storage, and efficient power and cooling management. The company's diverse clientele spans multiple sectors, including education, finance, government, healthcare, technology, media, and service providers, reflecting its broad applicability in the data storage market.

Intarcia Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for chronic conditions requiring long-term treatment. The company is known for its innovative drug delivery platform, DUROS, which stabilizes and administers therapeutic proteins and peptides effectively. Among its key products is ITCA 650, currently in phase 3 clinical trials for type 2 diabetes, designed to provide patients with continuous dosing of an incretin mimetic therapy. Intarcia also explores treatments for obesity and other chronic disorders. Established in 1995 and headquartered in Boston, Massachusetts, Intarcia operates a manufacturing facility in Hayward, California, and a research and development center in Durham, North Carolina. The company was previously known as BioMedicines, Inc. before adopting its current name in 2004.

SparkCharge, established in 2017 and based in Somerville, Massachusetts, specializes in manufacturing portable electric vehicle (EV) charging stations. Their products offer fast charging capabilities and modular design for enhanced flexibility. SparkCharge aims to address the challenges of wired infrastructure by providing mobile charging solutions that eliminate the need for gas-polluting generators or external power sources.